4D Molecular Therapeutics
FDMT
FDMT
94 hedge funds and large institutions have $522M invested in 4D Molecular Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
16% less capital invested
Capital invested by funds: $622M → $522M (-$99.5M)
29% less call options, than puts
Call options by funds: $1.85M | Put options by funds: $2.6M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
94
Holding in Top 10
–
Calls
$1.85M
Puts
$2.6M
Top Buyers
| 1 | +$13.9M | |
| 2 | +$12M | |
| 3 | +$7.56M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$7.07M |
| 5 |
Morgan Stanley
New York
|
+$4.87M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$6.51M | |
| 3 | -$6.38M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$5.18M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$4.36M |